Literature DB >> 8167901

Cell death induced in L-cells by treatment with thymidine: staging of the process and relationship to apoptosis.

J S Amenta1, M J Sargus, F M Baccino, C Sacchi, G Bonelli.   

Abstract

The purpose of this study was to characterize the stages in the development of thymidine-induced cell death. L-cells were characterized by both morphologic and quantitative techniques and evaluated at 24, 48, and 72 h of treatment. Cells first enlarged (stage I); about 50% of these enlarged cells then decreased in size with blebbing and compacting (stage II). This residual cell body transformed into a smooth eosinophilic hyaline body (stage III) by 72 h, many of which could be identified within the vacuolar system of viable cells. These changes were reflected in morphologic counts and Coulter sizing. Cell death (loss of labeled DNA) began in stage II and was most prominent in stage III. No cleavage of DNA into oligonucleosomal fragments was detected by agarose gel electrophoresis at any stage. The similarity of these changes to the complete spectrum of apoptosis in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8167901     DOI: 10.1007/bf02631363

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  27 in total

Review 1.  The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants.

Authors:  G B Corcoran; S D Ray
Journal:  Toxicol Appl Pharmacol       Date:  1992-04       Impact factor: 4.219

2.  Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action.

Authors:  L Fesus; V Thomazy; F Autuori; M P Ceru; E Tarcsa; M Piacentini
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

3.  A probable role for protein synthesis in intestinal epithelial cell damage induced in vivo by cytosine arabinoside, nitrogen mustard, or X-irradiation.

Authors:  M W Lieberman; R S Verbin; M Landay; H Liang; E Farber; T N Lee; R Starr
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

4.  Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis.

Authors:  A H Wyllie; R G Morris; A L Smith; D Dunlop
Journal:  J Pathol       Date:  1984-01       Impact factor: 7.996

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells.

Authors:  J Searle; T A Lawson; P J Abbott; B Harmon; J F Kerr
Journal:  J Pathol       Date:  1975-07       Impact factor: 7.996

7.  Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation.

Authors:  A L Kung; A Zetterberg; S W Sherwood; R T Schimke
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

8.  Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia.

Authors:  W Bursch; H S Taper; B Lauer; R Schulte-Hermann
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

9.  Evidence for a special relationship between proteolysis and single cell necrosis.

Authors:  J S Amenta; S C Brocher; J Mehta; D Manjunath; F M Baccino
Journal:  Toxicol Pathol       Date:  1986       Impact factor: 1.902

10.  Inhibition of basal protein degradation in rat embryo fibroblasts by cycloheximide: correlation with activities of lysosomal proteases.

Authors:  J S Amenta; M J Sargus; F M Baccino
Journal:  J Cell Physiol       Date:  1978-12       Impact factor: 6.384

View more
  1 in total

1.  Flow cytometric DNA content analysis of thymidine-induced cell death.

Authors:  G J Naus; M J Sargus; G Trucco; J S Amenta
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-01       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.